CAS Clinical Trial
Official title:
Cumulated Ambulation Score and Length of Hospital Stay After TKA
Verified date | June 2015 |
Source | University of Lausanne Hospitals |
Contact | n/a |
Is FDA regulated | No |
Health authority | Switzerland: Swissmedic |
Study type | Observational [Patient Registry] |
The purpose of the study is to prospectively evaluate patients who underwent total knee arthroplasty (TKA) using the Cumulated Ambulation Score (CAS)
Status | Completed |
Enrollment | 73 |
Est. completion date | June 2015 |
Est. primary completion date | September 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: Adults after elective TKA - Exclusion Criteria: No consent form signed, neurological impairment |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Switzerland | CHUV - Hopital Orthopedique | Lausanne | Vaud |
Lead Sponsor | Collaborator |
---|---|
University of Lausanne Hospitals |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Destination at the end of the hospitalisation | Record the patients' destination at the end of the in-hospital stay: home, rehabilitation centre, residential home or other. | at the moment of departure from in-hospital care | No |
Primary | CAS value | Record the CAS values for the first three operative days as mentioned in the protocol | The 3rd day after TKA | No |
Secondary | Length of stay | Record number of in-hospital days | between 4 days and 2 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04825145 -
Preeclampsia and Contact Activation
|